Tr. Downie et al., A SURVEY OF USE OF UNRELATED VOLUNTEER DONOR BONE-MARROW TRANSPLANTATION AT 46 CENTERS WORLDWIDE, 1989-93, Bone marrow transplantation, 15(4), 1995, pp. 499-503
Unrelated donor bone marrow transplantation is increasingly used to tr
eat haemopoietic disorders where no HLA-identical sibling is available
. The International Marrow Unrelated Search and Transplant Study has c
ollected core data on consecutive unrelated donor BMT (UD-BMT) and HLA
-identical sibling donor BMT (ID-BMT) performed in 46 participating ce
ntres world-wide between March 1989 and February 1993. Eighteen UD-BMT
were performed in the first 6-month period in 14 participating centre
s, while in the last period there were 103 UD-BMT in 46 centres. The p
ercentage of BMT recipients with the following diagnoses were: bone ma
rrow failure UD-BMT 15% and ID-BMT 11%; AML 13% and 27%; ALL 18% and 1
7%; CML 48% and 31%; and other diseases 7% and 14%. Thirty-eight per c
ent of UD-BMT recipients had advanced disease compared with only 23% o
f ID-BMT recipients. Thirty six per cent of UD-BMT compared with 21% o
f ID-BMT recipients were under 16 years old, More extreme differences
in pre-transplant clinical characteristics between UD and ID-BMT recip
ients were found when diagnosis and stage of disease were considered t
ogether, This survey indicates how UD and ID-BMT are currently used in
the treatment of haematological disease; however, longer follow-up is
required to assess the value of UD-BMT in the management of patients
with bone marrow disorders.